Literature DB >> 21605722

Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart.

Vincent M Figueredo1.   

Abstract

The heart is a target of injury for many chemical compounds, both medically prescribed and not medically prescribed. Pathophysiologic mechanisms underlying the development of chemical-induced cardiomyopathies vary depending on the inciting agent, including direct toxic effects, neurohormonal activation, altered calcium homeostasis, and oxidative stress. Numerous chemicals and drugs are implicated in cardiomyopathy. This article discusses examples of medication and nonprescribed drug-induced cardiomyopathies and reviews their pathophysiologic mechanisms.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21605722     DOI： 10.1016/j.amjmed.2010.11.031

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


  16 in total

1.  Cardiovascular disease among people with drug use disorders.

Authors:  Birgitte Thylstrup; Thomas Clausen; Morten Hesse
Journal:  Int J Public Health       Date:  2015-06-24       Impact factor: 3.380

2.  Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion.

Authors:  Carl E Wolf; Justin L Poklis; Kirk Cumpston; Michael Moss; Alphonse Poklis
Journal:  Drug Test Anal       Date:  2016-05-30       Impact factor: 3.345

Review 3.  Alcohol and cardiovascular disease in the geriatric population.

Authors:  Aditi Kalla; Vincent M Figueredo
Journal:  Clin Cardiol       Date:  2017-03-10       Impact factor: 2.882

4.  Clozapine linked to nanocapsules minimizes tissue and oxidative damage to biomolecules lipids, proteins and DNA in brain of rats Wistar.

Authors:  Angélica Aparecida da Costa Güllich; Ritiéle Pinto Coelho; Bruna Cocco Pilar; Deise Jaqueline Ströher; Leandro Alex Sander Leal Galarça; Simone Machado Vieira; Jacqueline da Costa Escobar Piccoli; Sandra Elisa Haas; Vanusa Manfredini
Journal:  Metab Brain Dis       Date:  2014-10-09       Impact factor: 3.584

5.  Cardiac effects of echinocandins after central venous administration in adult rats.

Authors:  Christian Koch; Florian Uhle; Matthias Wolff; Christoph Arens; Astrid Schulte; Ling Li; Bernd Niemann; Michael Henrich; Susanne Rohrbach; Markus A Weigand; Christoph Lichtenstern
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

Review 6.  A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review.

Authors:  Karsten Keller; Johannes Beule; Jörn Oliver Balzer; Meike Coldewey; Thomas Munzel; Wolfgang Dippold; Philipp Wild
Journal:  Wien Klin Wochenschr       Date:  2013-12-17       Impact factor: 1.704

7.  A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.

Authors:  Jessica A Palmer; Alan M Smith; Vitalina Gryshkova; Elizabeth L R Donley; Jean-Pierre Valentin; Robert E Burrier
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

Review 8.  Myocarditis: A Clinical Overview.

Authors:  A L P Caforio; G Malipiero; R Marcolongo; S Iliceto
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 3.955

Review 9.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24

10.  Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized Study.

Authors:  Sang-Ho Jo; Lee Su Kim; Sung-Ai Kim; Hyun-Sook Kim; Sang-Jin Han; Woo Jung Park; Young Jin Choi
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.